Supplementary Material for: Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients Matsui M. Samejima K. Takeda Y. Tanabe K. Morimoto K. Okamoto K. Tagawa M. Onoue K. Okayama S. Kawata H. 10.6084/m9.figshare.5128651.v1 https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Prognostic_Impact_of_Placental_Growth_Factor_on_Mortality_and_Cardiovascular_Events_in_Dialysis_Patients/5128651 <b><i>Background:</i></b> Placental growth factor (PlGF), a member of the vascular endothelial growth factor (VEGF) family, has recently emerged as a predictor of survival and cardiovascular risk. Along with others, we have shown an independent association between PlGF and cardiovascular events in CKD patients, but not much is known about patients receiving dialysis. <b><i>Methods:</i></b> We studied 205 dialysis patients undergoing cardiac catheterization at the Nara Medical University between April 1, 2004, and December 31, 2012. Serum levels of PlGF and VEGF were measured with ELISA in all the patients. <b><i>Results:</i></b> During a median follow-up of 20 months, 121 participants died from any cause or experienced a cardiovascular event. In the fully adjusted analysis, having an above-median PlGF or VEGF level was associated with a hazards ratio for adverse outcomes of 2.55 (1.72-3.83) and 1.39 (0.95-2.04), respectively. Using a multimarker strategy in a model with age, serum albumin, history of coronary artery disease, brain natriuretic peptide and PlGF, patients with 2, 3 and 4 positive markers had a 3.82-, 5.77- and 6.59-fold higher risk of mortality or a cardiovascular event, respectively, compared to those with no positive markers. The model with PlGF had a significantly higher c-statistic, integrated discrimination improvement index and category-free net reclassification improvement index than the model without PlGF. <b><i>Conclusion:</i></b> PlGF is independently associated with mortality and cardiovascular events, but the association between VEGF and adverse events was attenuated with covariate adjustment. The addition of PlGF to models with established clinical predictors provides additional useful prognostic information in patients receiving dialysis. 2015-09-15 00:00:00 Placental growth factor Vascular endothelial growth factor Cardiovascular events Dialysis patients